A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Roxadustat for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Roxadustat for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis
The purpose of the study is to evaluate the safety and efficacy of roxadustat for treatment of anemia in patients with chronic kidney disease not on dialysis
This is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study in anemic patients with Stage 3, 4 or 5 chronic kidney disease (CKD) who are not on dialysis.
Inclusion Criteria:
Exclusion Criteria:
CABA, C1012AAR, Argentina
CABA, C1440AAD, Argentina
Capital Federal, C1425AGC, Argentina
Ciudad Autónoma de Bs. As., C1199ABB, Argentina
Ghaziabad NCR, 201012, India
Maharashtra, 411013, India
Khmelnytsky, 29000, Ukraine
Hochiminh, 550000, Vietnam
Hochiminh, 700000, Vietnam